Rie Yanagisawa Selected Research

Rie Yanagisawa Research Topics

Disease

50	Inflammation (Inflammations) 12/2021 - 01/2002
28	Pneumonia (Pneumonitis) 10/2021 - 05/2002
19	Asthma (Bronchial Asthma) 01/2022 - 01/2002
11	Acute Lung Injury 11/2008 - 12/2002
9	Atopic Dermatitis (Atopic Eczema) 12/2021 - 08/2006
8	Lung Injury 04/2011 - 04/2002
5	Body Weight (Weight, Body) 01/2019 - 04/2004
5	Disseminated Intravascular Coagulation 07/2009 - 03/2005
5	Shock 07/2009 - 03/2005
5	Pancreatitis 07/2009 - 03/2005
4	Obesity 01/2019 - 04/2007
4	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2014 - 04/2002
4	Hemorrhage 01/2013 - 05/2002
4	Arthritis (Polyarthritis) 01/2007 - 08/2003
3	Hypersensitivity (Allergy) 04/2010 - 11/2005
3	Infections 03/2007 - 10/2004
3	Lung Diseases (Lung Disease) 11/2006 - 04/2003
3	Pulmonary Edema 09/2006 - 12/2002
2	Respiratory Hypersensitivity 01/2019 - 08/2007
2	Skin Diseases (Skin Disease) 02/2014 - 03/2009
2	Colitis 05/2013 - 08/2004
2	Eosinophilia 10/2010 - 08/2010
2	Hyperplasia 04/2010 - 08/2007
2	Diabetes Mellitus 04/2007 - 01/2007
2	Rheumatoid Arthritis 07/2004 - 07/2003
2	Edema (Dropsy) 04/2003 - 05/2002
1	Necrosis 01/2022
1	Anemia 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hyperglycemia 01/2019
1	Type 2 Diabetes Mellitus (MODY) 08/2014

Drug/Important Bio-Agent (IBA)

29	CytokinesIBA 01/2019 - 01/2002
22	Vehicle Emissions (Emissions, Vehicle)IBA 06/2014 - 04/2002
22	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2013 - 04/2002
22	LipopolysaccharidesIBA 01/2009 - 12/2002
18	AllergensIBA 01/2022 - 01/2002
13	ChemokinesIBA 01/2019 - 05/2002
12	EndotoxinsIBA 09/2007 - 05/2002
10	AntigensIBA 02/2009 - 08/2003
8	Immunoglobulin G (IgG)IBA 01/2019 - 01/2002
8	Particulate MatterIBA 06/2014 - 09/2006
7	Interleukin-6 (Interleukin 6)IBA 01/2017 - 06/2004
7	Immunoglobulins (Immunoglobulin)IBA 02/2014 - 07/2002
6	SandIBA 01/2012 - 11/2005
6	Proteins (Proteins, Gene)FDA Link 04/2010 - 01/2004
6	urinastatin (MR 20)IBA 07/2009 - 03/2005
5	Interleukin-5 (Interleukin 5)IBA 11/2020 - 01/2002
5	phthalic acid (phthalate)IBA 02/2014 - 08/2006
5	Organic Chemicals (Chemicals, Organic)IBA 01/2013 - 11/2004
5	Chemotactic FactorsIBA 12/2012 - 04/2004
5	OvalbuminIBA 06/2012 - 07/2002
5	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 07/2009 - 03/2005
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 10/2019 - 04/2002
4	Immunoglobulin E (IgE)IBA 01/2019 - 01/2002
4	Pharmaceutical PreparationsIBA 01/2017 - 03/2005
4	Diethylhexyl Phthalate (DEHP)IBA 02/2014 - 08/2006
4	MetallothioneinIBA 05/2013 - 01/2005
4	InterleukinsIBA 01/2007 - 06/2004
4	Rosmarinic AcidIBA 07/2006 - 04/2003
3	SootIBA 04/2011 - 09/2006
3	Carbon Nanotubes (Carbon Nanotube)IBA 04/2010 - 12/2008
3	Interleukin-1beta (Interleukin 1 beta)IBA 03/2010 - 01/2004
3	AntioxidantsIBA 10/2009 - 12/2002
3	CarbonIBA 12/2008 - 09/2006
3	Vitamin E FDA LinkGeneric 10/2004 - 12/2002
2	Benzo(a)pyreneIBA 12/2021 - 11/2016
2	tris(1,3-dichloroisopropyl) phosphateIBA 10/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 04/2004
2	bisphenol AIBA 01/2019 - 01/2018
2	Drinking WaterIBA 01/2019 - 08/2004
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2014
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 07/2005
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 12/2002
2	PlasticizersIBA 08/2014 - 05/2009
2	LipidsIBA 03/2014 - 12/2012
2	diisononyl phthalateIBA 02/2014 - 04/2010
2	PeroxiredoxinsIBA 12/2012 - 10/2009
2	OzoneIBA 12/2012 - 12/2008
2	InflammasomesIBA 01/2012 - 10/2010
2	Pancreatic Elastase (Elastase)IBA 04/2011 - 03/2010
2	beta-GlucansIBA 07/2009 - 09/2007
2	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2008 - 03/2005
2	Interleukin-13IBA 08/2007 - 08/2005
2	RolipramIBA 01/2007 - 07/2004
2	Hemostatics (Antihemorrhagics)IBA 06/2006 - 06/2004
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2005 - 05/2002
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Heme Oxygenase-1IBA 01/2022
1	Flame Retardants (Fire Retardants)IBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	IronIBA 01/2021
1	Chemokine CCL11IBA 11/2020
1	Estrogen Receptor alphaIBA 11/2020
1	A-factor (Streptomyces)IBA 01/2019
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019